TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Takeda Pharma A/S
Closing information (x1000 SEK)
| Closing information | 2025/03 | 2024/03 | 2023/03 |
| Turnover |
1,602,957
|
1,728,765
|
1,606,455 |
| Earnings before taxes |
24,929
|
518,806
|
31,566 |
| Total assets |
845,281
|
899,948
|
735,329 |
| Current assets |
818,737
|
845,310
|
621,016 |
| Current liabilities |
296,158
|
333,353
|
568,087 |
| Equity capital |
535,513
|
550,058
|
143,648 |
| - share capital |
14,686
|
15,608
|
15,289 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Solvency |
63.4%
|
61.1%
|
19.5% |
| Turnover per employee |
4,580
|
4,939
|
4,590 |
| Profit as a percentage of turnover |
1.6%
|
30.0%
|
2.0% |
| Return on assets (ROA) | |||
| Current ratio |
276.5%
|
253.6%
|
109.3% |
| Return on equity (ROE) |
4.7%
|
94.3%
|
22.0% |
| Change turnover |
-23,688
|
88,862
|
228,808 |
| Change turnover % |
-1%
|
5%
|
17% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.